Cell And Gene Therapy Supply Chain/Logistics Market Overview 2023-2032 – Market Growth AnalysisPosted by Ramakrishna TBRC on October 30th, 2023 The Business Research Company’s Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2023 evaluates cell and gene therapy supply chain/logistics market size, growth rate, drivers, trends, and major companies. The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The global cell and gene therapy supply chain/logistics market is expected to grow from .1 billion in 2022 to .25 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The cell and gene therapy supply chain/logistics market is expected to reach .93 billion in 2027 at a CAGR of 11.5%. The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain/logistics market. Cell and gene therapies are advanced medical treatments that modify cells or genes to treat diseases, offering potential breakthroughs for untreatable conditions. These cell and gene therapies need to be stored at the proper temperature and storage conditions, which can be achieved using supply chain and logistics services, which help from sourcing to distributing and storing these cell and gene therapies. For instance, in February 2022, according to Cell & Gene, a US-based online resource for research scholars, the private investment in cell and gene therapy in 2021 was billion, up from 2 million in 2020. Moreover, the number of approved cell and gene therapies experienced a 10% growth in 2021. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain/logistics market forward. Get More Information On The Cell And Gene Therapy Supply Chain/Logistics Market Report: The cell and gene therapy supply chain/logistics market segments in the report are: 1) By ype Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System 2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution 3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components 4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up 5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization The table of contents in TBRC’s cell and gene therapy supply chain/logistics market report includes:
. . .
Learn About Us:
Contact Us: Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info Like it? Share it! More by this author |